CA2168566A1 - Methode et reactif provoquant l'inhibition de la replication du virus de l'immunodeficience humaine - Google Patents

Methode et reactif provoquant l'inhibition de la replication du virus de l'immunodeficience humaine

Info

Publication number
CA2168566A1
CA2168566A1 CA 2168566 CA2168566A CA2168566A1 CA 2168566 A1 CA2168566 A1 CA 2168566A1 CA 2168566 CA2168566 CA 2168566 CA 2168566 A CA2168566 A CA 2168566A CA 2168566 A1 CA2168566 A1 CA 2168566A1
Authority
CA
Canada
Prior art keywords
ribozyme
rna
nucleic acid
seq
ribozymes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2168566
Other languages
English (en)
Inventor
Kenneth G. Draper
Bharat Chowrira
James Mcswiggen
Daniel T. Stinchcomb
James D. Thompson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sirna Therapeutics Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/271,880 external-priority patent/US5693535A/en
Application filed by Individual filed Critical Individual
Publication of CA2168566A1 publication Critical patent/CA2168566A1/fr
Abandoned legal-status Critical Current

Links

Abstract

Molécule d'acide nucléique enzymatique effectuant le clivage d'un ARN du virus de l'immunodéficience dans un gène nécessaire à la réplication virale, par exemple les régions du gène nef ou tat.
CA 2168566 1993-08-06 1994-08-04 Methode et reactif provoquant l'inhibition de la replication du virus de l'immunodeficience humaine Abandoned CA2168566A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US10342393A 1993-08-06 1993-08-06
US08/271,880 US5693535A (en) 1992-05-14 1994-07-07 HIV targeted ribozymes
US08/271,880 1994-07-07
US08/103,423 1994-07-07

Publications (1)

Publication Number Publication Date
CA2168566A1 true CA2168566A1 (fr) 1995-02-16

Family

ID=26800447

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2168566 Abandoned CA2168566A1 (fr) 1993-08-06 1994-08-04 Methode et reactif provoquant l'inhibition de la replication du virus de l'immunodeficience humaine

Country Status (4)

Country Link
EP (1) EP0716693A1 (fr)
JP (1) JPH09501318A (fr)
CA (1) CA2168566A1 (fr)
MX (1) MX9406022A (fr)

Also Published As

Publication number Publication date
EP0716693A1 (fr) 1996-06-19
MX9406022A (es) 1997-08-30
JPH09501318A (ja) 1997-02-10

Similar Documents

Publication Publication Date Title
US5693535A (en) HIV targeted ribozymes
US5795778A (en) Method and reagent for inhibiting herpes simplex virus replication
US6017756A (en) Method and reagent for inhibiting hepatitis B virus replication
US5989906A (en) Method and reagent for inhibiting P-glycoprotein (mdr-1-gene)
US5610054A (en) Enzymatic RNA molecule targeted against Hepatitis C virus
US6432704B1 (en) Method and reagent for inhibiting herpes simplex virus replication
EP0786522A2 (fr) Molécules de RNA enzymatiques pour le traitement de conditions sténotiques
WO1995004818A1 (fr) Procede et reactif servant a inhiber la replication du virus de l'immunodeficience humaine
US5750390A (en) Method and reagent for treatment of diseases caused by expression of the bcl-2 gene
CA2135499A1 (fr) Methode et reagent pour l'inhibition de la cancerogenese
US5616490A (en) Ribozymes targeted to TNF-α RNA
US5599704A (en) ErbB2/neu targeted ribozymes
CA2175824A1 (fr) Methode de traitement d'etats arthritiques et reactif utilise dans celle-ci
US5801158A (en) Enzymatic RNA with activity to RAS
US5622854A (en) Method and reagent for inhibiting T-cell leukemia virus replication
US5639655A (en) PML-RARA targeted ribozymes
US6258585B1 (en) Method and reagent for inhibiting influenza virus replication
WO1994029452A2 (fr) Molecule d'arn enzymatique pour le traitement de la fibrose et de la maladie du tissu fibreux
CA2168566A1 (fr) Methode et reactif provoquant l'inhibition de la replication du virus de l'immunodeficience humaine
US6492512B1 (en) Method and reagent for treatment of lung cancer and other malignancies caused by the deregulation of L-MYC gene expression
AU7375594A (en) Method and reagent for inhibiting human immunodeficiency virus replication
US6544755B1 (en) Method and reagent for treatment of diseases by expression of the c-Myc gene
AU3340101A (en) Method and reagent for inhibiting human immunodeficiency virus replications
AU9825398A (en) Method and reagent for inhibiting human immunodeficiency virus replication
AU5661700A (en) Method and reagent for treatment of animal diseases

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead